Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Durando

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Radiation Oncology (London, England)|December 8, 2017
Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" reportJ Biau, E Chautard, E De Schlichting, et al.
Clinical and Translational Radiation Oncology|August 26, 2024
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistributionJ Biau, X Durando, F Boux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastomaJ Biau, E Thivat, E Chautard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trialS Leyvraz, S Piperno-Neumann, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
International Journal of Cancer|December 10, 2015
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancerJ M Nabholtz, N Chalabi, N Radosevic-Robin, et al.
Diagnostic and Interventional Imaging|November 10, 2020
Artificial intelligence solution to classify pulmonary nodules on CTD Blanc, V Racine, A Khalil, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
Lung Cancer (Amsterdam, Netherlands)|October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinibE Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Radiation Oncology (London, England)|December 8, 2017
Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" reportJ Biau, E Chautard, E De Schlichting, et al.
Clinical and Translational Radiation Oncology|August 26, 2024
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistributionJ Biau, X Durando, F Boux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastomaJ Biau, E Thivat, E Chautard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trialS Leyvraz, S Piperno-Neumann, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
International Journal of Cancer|December 10, 2015
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancerJ M Nabholtz, N Chalabi, N Radosevic-Robin, et al.
Diagnostic and Interventional Imaging|November 10, 2020
Artificial intelligence solution to classify pulmonary nodules on CTD Blanc, V Racine, A Khalil, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
Lung Cancer (Amsterdam, Netherlands)|October 21, 2019
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinibE Thunnissen, B I Lissenberg-Witte, M M van den Heuvel, et al.
Pageof 3